Trial Profile
Proximal tubular impairment in HIV-positive patients receiving tenofovir disoproxil fumarate, and association between tenofovir concentration and urinary retinol binding protein (RBP) levels
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 09 Dec 2015 New trial record
- 03 Dec 2015 Results published in the AIDS